CTF Systems CE-marks OMEGA MEG (magnetoencephalography) systems:
This article was originally published in Clinica
Executive Summary
VSM MedTech's wholly owned subsidiary, CTF Systems, has CE-marked its OMEGA whole-cortex magnetoencephalography (MEG) systems, a move that will allow the systems to be marketed in all member states in Europe and other countries that recognise the CE marking. Previously, the firm's MEG system installations were granted CE markings on an individual basis. "This blanket CE marking eliminates the effort and costs associated with obtaining approvals on a system-by-system basis and should accelerate the sales cycle in Europe, said Vancouver, Canada-based VSM.
You may also be interested in...
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.
Merck’s Winrevair Well Positioned To Benefit From Medicare Part D Redesign
Significant cost sharing reductions under the redesign will enhance uptake of the pulmonary arterial hypertension drug. The trade-off is a 20% mandatory price discount in the catastrophic phase.